Exane Derivatives’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,300
Closed -$71.5K 1056
2021
Q1
$71.5K Buy
+2,300
New +$71.5K 0.02% 464